The new policy, announced on July 25, 2026, marks a significant shift in how women's sports leagues approach athlete eligibility and health.
By requiring genetic testing, tennis aims to ensure a level playing field and address concerns regarding performance-enhancing substances.
This decision sets a precedent that may influence other women's leagues to reconsider their policies on genetic testing and athlete health.